Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism

被引:5
|
作者
Arslan, Derya [1 ]
Buyukinan, Muammer [2 ]
Uysal, Celil [3 ]
Deniz, Cigdem Damla [4 ]
机构
[1] Konya Training & Res Hosp, Univ Hlth Sci, Dept Pediat Cardiol, Konya, Turkey
[2] Konya Training & Res Hosp, Dept Pediat Endocrinol, Konya, Turkey
[3] Patnos State Hosp, Dept Pediat, Agri, Turkey
[4] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey
关键词
Subclinical hypothyroidism; Cardiovascular risk; GDF-15; Child; HEART-FAILURE; GUIDELINES; ECHOCARDIOGRAPHY; ASSOCIATION; CHILDHOOD; HORMONE; DISEASE;
D O I
10.1007/s12020-019-01933-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Subclinical hypothyroidism, defined as increased TSH serum levels and normal serum free T4 concentrations, has been associated with an increased risk of heart disease in adults. But, data in children and adolescents are scanty and treatment of subclinical hypothyroidism is controversial. Growth differentiation factor-15 (GDF-15) is a promising biomarker of cardiac remodeling. This study aimed to evaluate the cardiovascular risk factors in children with subclinical hypothyroidism, measured with tissue Doppler echocardiography (TDE), and conventional echocardiography and GDF-15 level. Methods The study comprised a total of 41 pediatric patients with subclinical hypothyroidism (SH) (mean age 9.6 +/- 4.7 years) and 31 healthy children (mean age 11.2 +/- 3.4 years) as the control group. Subclinical hypothyroidism was defined as a thyroid-stimulating hormone level higher than 4 mIU/l and a normal free-thyroxine level (0.6-1.8 ng/dl). Tissue Doppler echocardiography was performed to all individuals in the control group and patient group at the beginning of the study. Global systolic function as assessed by left ventricular ejection fraction was compared between groups. The serum GDF-15 level was measured. Results There were no significant differences in demographic parameters between the SH and control groups. The left ventricular internal diameter end systole, interventricular septal end diastole, left ventricular posterior wall end diastole, and tricuspid annular plane systolic excursion values were significantly different between the SH and control groups (p = 0.038, 0.028, 0.005, and 0.000, respectively). The mean mitral isovolumic relaxation time value of the SH group was 57.2 +/- 9.3 ms, compared to 44.5 +/- 5.6 ms for the control group (p = 0.000). The mean tricuspid isovolumic contraction time value of the SH group was 58.7 +/- 9.4 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). The mean tricuspid isovolumic relaxation time value of the SH group was 58.03 +/- 9.5 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). There were no significant differences in the other m-mode or pulse Doppler echocardiography values between two groups. The GDF-15 value of the SH group was 382.6 +/- 268.2 pg/mL, and that of the control group was 473.6 +/- 337.9 pg/mL; this difference was not significant. Conclusion Patients with subclinical hypothyroidism versus healthy individuals had some changes in echocardiographic parameters that indicate involvement of diastolic function of the left ventricle. They were significantly different when compared SH group and the control group. This study demonstrated ventricle diastolic dysfunction in pediatric patients with hypothyroidism. The results of our study suggest that cardiac follow-up may be useful in patients with subclinical hypothyroidism and clinical trials are needed to explore therapeutic effects of T4 and T3 administration in this patients.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 50 条
  • [1] Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism
    Derya Arslan
    Muammer Buyukinan
    Celil Uysal
    Cigdem Damla Deniz
    Endocrine, 2019, 65 : 601 - 607
  • [2] Growth-differentiation factor-15 in cardiovascular disease
    Wollert, Kai C.
    BASIC RESEARCH IN CARDIOLOGY, 2007, 102 (05) : 412 - 415
  • [3] Growth-differentiation factor-15 and tissue doppler imaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors
    Arslan, Derya
    Cihan, Tugba
    Kose, Dogan
    Vatansev, Husamettin
    Cimen, Derya
    Koksal, Yavuz
    Oran, Bulent
    Akyurek, Fikret
    CLINICAL BIOCHEMISTRY, 2013, 46 (13-14) : 1239 - 1243
  • [4] Growth-differentiation factor-15 in cardiovascular diseaseFrom bench to bedside, and back
    K. C. Wollert
    Basic Research in Cardiology, 2007, 102 : 412 - 415
  • [5] Growth-differentiation Factor-15 and Tissue Doppler Imaging in Detection of Anthracycline-induced Cardiomyopathy During Therapy of Childhood Cancers
    Kaya, Fatma
    Arslan, Derya
    Vatansev, Husamettin
    Kose, Dogan
    Cimen, Derya
    Akyurek, Fikret
    Oran, Bulent
    Koksal, Yavuz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (03) : E107 - E112
  • [6] Growth-Differentiation Factor-15 and Major Cardiac Events
    Lin, Jeng-Feng
    Wu, Semon
    Hsu, Shun-Yi
    Yeh, Kuan-Hung
    Chou, Hsin-Hua
    Cheng, Shih-Tsung
    Wu, Tien-Yu
    Hsu, Wen-Tze
    Yang, Chun-Chun
    Ko, Yu-Lin
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (04): : 305 - 311
  • [7] Growth-differentiation Factor-15 Contributes to Evaluation of Cardiovascular Risk in Healthy Elderly Men in Addition to Cardiovascular History, Risk Factors and Other Biomarkers
    Wallentin, Lars
    Berglund, Lars
    Kempf, Tibor
    Lindahl, Bertil
    Wollert, Kai C.
    Zethelius, Bjorn
    Siegbahn, Agneta
    CIRCULATION, 2010, 122 (21)
  • [8] Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain
    Eggers, Kai M.
    Kempf, Tibor
    Allhoff, Tim
    Lindahl, Bertil
    Wallentin, Lars
    Wollert, Kai C.
    EUROPEAN HEART JOURNAL, 2008, 29 (19) : 2327 - 2335
  • [9] Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain
    Egger, Kai M.
    Kempf, Tibor
    Lindahl, Berti
    Wallentin, Lars
    Wollert, Kai C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 200A - 200A
  • [10] Growth-differentiation factor-15 for risk stratification in patients with acute chest pain: reply
    Eggers, Kai M.
    Wallentin, Lars
    Wollert, Kai C.
    EUROPEAN HEART JOURNAL, 2008, 29 (23) : 2947 - 2948